Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Temporal trends in retrograde crossing of epicardial collaterals in chronic total occlusion percutaneous coronary intervention.

International journal of cardiology·2026
Same author

Reverse Crush Versus Culotte in Bifurcation Lesions After Provisional Stenting: Insights From the PROGRESS-BIFURCATION Registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Response to "Revascularization reporting and procedural details in ostial stenting outcomes".

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same author

Database of tensile test results of carbon fibers impregnated with thermoplastic polymer.

Scientific data·2026
Same author

Impact of Adherence to the Global Algorithm for Initial Crossing Strategy Selection in Chronic Total Occlusion Percutaneous Coronary Intervention.

The American journal of cardiology·2026
Same author

Long-term outcomes after ostial stenting for 0.0.1 and 0.1.0 coronary bifurcation lesions. Results from the real-world multicenter registry.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same journal

Novel Parent Survey Measures Sensory Behaviors Incorporating Sensory Modality and Stimulus Intensity.

Heliyon·2026
Same journal

Expression of concern: "SQSTM1/p62 promotes the progression of gastric cancer through epithelial-mesenchymal transition" [Heliyon 10 (2024) e24409].

Heliyon·2026
Same journal

Expression of concern: "TL1A promotes metastasis and EMT process of colorectal cancer" [Heliyon 10 (2024) e24392].

Heliyon·2026
Same journal

Expression of concern: "Factors affecting timing of surgery following neoadjuvant chemoradiation for esophageal cancer" [Heliyon 9 (2023) e23212].

Heliyon·2026
Same journal

Expression of concern: "On stratified single-valued soft topogenous structures" [Heliyon 10 (2024) e27926].

Heliyon·2026
Same journal

Expression of concern: "Artifact removal and motor imagery classification in EEG using advanced algorithms and modified DNN" [Heliyon 10 (2024) e27198].

Heliyon·2026
查看所有相关文章

相关实验视频

Updated: May 11, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.3K

干预心脏病学的人工智能:创新和挑战

Dmitrii Khelimskii1, Aram Badoyan1, Oleg Krymcov1

  • 1Meshalkin National Medical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.

Heliyon
|September 16, 2024
PubMed
概括
此摘要是机器生成的。

人工智能 (AI) 在干预心脏病学中提供了显著的潜力,改善了冠状动脉心脏病的诊断和治疗. 这篇概述探讨了AI.

更多相关视频

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

4.9K
Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

982

相关实验视频

Last Updated: May 11, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.3K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

4.9K
Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

982

科学领域:

  • 医疗技术 医疗技术 医学技术
  • 心脏病学 心脏病学
  • 人工智能的人工智能

背景情况:

  • 人工智能 (AI) 越来越多地融入日常生活和医学.
  • 人工智能在各种科学和技术领域已经证明了其有效性.
  • 干预性心脏病学广泛利用可视化技术进行诊断和治疗.

研究的目的:

  • 提供人工智能研究在干预心脏病学中的概述.
  • 讨论AI在这个领域的实际应用.
  • 确定阻碍人工智能在干预心脏病学中广泛应用的挑战.

主要方法:

  • 审查目前的AI研究在干预心脏病学.
  • 分析患者护理中的实际人工智能应用.
  • 识别人工智能实施的障碍.

主要成果:

  • 人工智能技术在干预心脏病学中正在积极研究和实施.
  • 人工智能显示出降低成本和改善患者治疗结果的潜力.
  • 具体的挑战阻碍了神经网络在临床实践中的广泛使用.

结论:

  • 人工智能在推进干预心脏病学方面具有相当大的前景.
  • 需要进一步的研究和开发来克服实施障碍.
  • 人工智能的广泛采用可以提高冠心病的诊断和治疗.